A Call to Action: Warfarin Patient Self‐management

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACYVolume 7, Issue 3 p. 196-197 EDITORIAL A call to action: Warfarin patient self-management Sarah A. Spinler Pharm.D., FCCP, Corresponding Author Sarah A. Spinler Pharm.D., FCCP [email protected] orcid.org/0000-0003-4552-0053 Department of Pharmacy Practice, Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, New York, USA Correspondence Sarah A. Spinler, Department of Pharmacy Practice, Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton University, PO Box 6000, Binghamton, NY 13902-6000, USA. Email: [email protected]Search for more papers by this author Sarah A. Spinler Pharm.D., FCCP, Corresponding Author Sarah A. Spinler Pharm.D., FCCP [email protected] orcid.org/0000-0003-4552-0053 Department of Pharmacy Practice, Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, New York, USA Correspondence Sarah A. Spinler, Department of Pharmacy Practice, Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton University, PO Box 6000, Binghamton, NY 13902-6000, USA. Email: [email protected]Search for more papers by this author First published: 18 March 2024 https://doi.org/10.1002/jac5.1937Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. CONFLICT OF INTEREST STATEMENT The author declares no conflict of interest. Open Research DATA AVAILABILITY STATEMENT Data sharing not applicable to this article as no datasets were generated or analysed during the current study. REFERENCES 1Ansell JE, Hughes R. Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management. Am Heart J. 1996; 132(5): 1095–1100. https://doi.org/10.1016/s0002-8703(96)90040-x 10.1016/S0002-8703(96)90040-X CASPubMedWeb of Science®Google Scholar 2Wilson AS, Slager S, Jones AE, Vazquez SR, Barnes GD, Sylvester K, et al. A qualitative study evaluating provider perceptions of implementing warfarin patient self-management in the United States' healthcare system. J Am Coll Clin Pharm. 2023; 6: 1295–1303. 10.1002/jac5.1879 Google Scholar 3Wilson AS, Slager S, Jones AE, Vazquez SR, Barnes GD, Sylvester K, et al. A qualitative study evaluating exploring patient experiences and opinions of warfarin in patient self-management in the US healthcare system. J Am Coll Clin Pharm. 2024; 7: 198–206. https://doi.org/10.1002/jac5.1912 10.1002/jac5.1912 Google Scholar 4 SPICe The Information Centre. Briefing for the Public Petitions Committee. https://archive2021.parliament.scot/ResearchBriefingsAndFactsheets/Petitions%20briefings%20S4/PB15-1566.pdf Google Scholar 5Le Heuzey JY, Ammentorp B, Darius H, De Caterina R, Schilling RJ, Schmitt J, et al. Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry. Thromb Haemost. 2014; 111(5): 833–841. CASPubMedWeb of Science®Google Scholar 6Heneghan CJ, Garcia-Alamino JM, Spencer EA, Ward AM, Perera R, Bankhead C, et al. Self-monitoring and self-management of oral anticoagulation. Cochrane Database Syst Rev. 2016; 7(7):CD003839. https://doi.org/10.1002/14651858 10.1002/14651858 PubMedGoogle Scholar 7Lip GYH, Banerjee A, Boriani G, Chiang C, Fargo R, Freedman B, et al. Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report. Chest. 2018; 154(5): 1121–1201. https://doi.org/10.1016/j.chest.2018.07.040 10.1016/j.chest.2018.07.040 PubMedWeb of Science®Google Scholar 8Witt DM, Nieuwlaat R, Clark NP, Ansell J, Holbrook A, Skov J, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Adv. 2018; 2(22): 3257–3291. https://doi.org/10.1182/bloodadvances.2018024893 10.1182/bloodadvances.2018024893 PubMedWeb of Science®Google Scholar 9Craig JA, Chaplin S, Jenks M. Warfarin monitoring economic evaluation of point of care self-monitoring compared to clinic settings. J Med Econ. 2014; 17(3): 184–190. https://doi.org/10.3111/13696998.2013.877468 10.3111/13696998.2013.877468 PubMedGoogle Scholar 10Fleming RP, Vazquez SR, Witt DM. Implementation and evaluation of a warfarin patient self-management (PSM) program among experienced patients in a U.S. academic health system. J Thromb Thrombolysis. 2023; 56(4): 511–513. https://doi.org/10.1007/s11239-023-02877-9 10.1007/s11239-023-02877-9 PubMedWeb of Science®Google Scholar Volume7, Issue3March 2024Pages 196-197 ReferencesRelatedInformation